Predicting Glioblastoma Response to Bevacizumab Through MRI Biomarkers of the Tumor Microenvironment.
Andreas StadlbauerKarl RoesslerMax ZimmermannMichael BuchfelderAndrea KleindienstArnd DoerflerGertraud HeinzStefan OberndorferPublished in: Molecular imaging and biology (2020)
TME mapping might be useful to develop strategies for patient stratification and response prediction before bevacizumab onset.